Document is current

Article History

Received: 4 July 2024

Accepted: 18 October 2024

First Online: 18 November 2024

Declarations

:

: The study protocol has been evaluated and authorized by the relevant institutional IEC/IRB (CPP Sud-Méditerranée IV, Montpellier, France; reference: 2021-A03211-40). The study sponsor (Lille University Hospital) is responsible for all administrative procedures. In accordance with French legislation, all the patients or their legal representative will be given verbal information about the study during the inclusion visit and will also receive a study information sheet. The patient can refuse to participate at any time. The study protocol has been registered with the French Consultative Committee on Information Processing in Medical Research and the French National Data Protection Commission. This trial was registered at ClinicalTrials.gov (NCT05923983) on February 9, 2023: with the title “DETECT-IP: a Clinical Decision Support System and Intelligent Procedures to Counter Some Adverse Drug Events in Older Hospital Patients”). Any substantial change in the protocol is subject to a written amendment submitted to the sponsor, who must seek approval from the IEC/IRB and authorization by the competent authority or authorities before implementation. All amendments to the protocol must be made known to all the study’s investigators.

: Not applicable-The participant information materials and informed consent form are available from the corresponding author on request.

: The authors declare that they have no competing interests.